Skip to main content

Abstract

Acute radiation proctopathy (ARP) and chronic radiation proctopathy (CRP) are common complications of pelvic radiation therapy. ARP is by definition a self-limited process and is characterized by abdominal symptoms and diarrhea that occur during radiation therapy. Treatment is directed at reduction of symptoms with stool bulking agents and anti-diarrheal medications. CRP occurs at least 3 months after completion of radiation therapy and is associated with significant morbidity. The most common symptom of CRP is rectal bleeding from rupture of mucosal telangiectasias and local mucosal ischemia. Functional symptoms occur from loss of rectal compliance and anal sphincter injury. These symptoms include urgency, tenesmus, increased stool frequency and fecal incontinence. These problems have received less attention in the medical literature. Profound blood loss and fistulization are severe conseq uences of CRP.

Argon plasma coagulation is recommended as optimal treatment for bleeding from telangiectasias. Retinol (retinyl) palmitate has demonstrated efficacy for functional symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Wang CJ, Leung SW, Chen HC, et al. The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma: evidence suggestive of consequential late effect (CQLE). Int J Radiat Oncol Biol Phys 1998;40(1):85–91.

    Article  CAS  PubMed  Google Scholar 

  2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.

    Article  PubMed  Google Scholar 

  3. Hong JJ, Park W, Ehrenpreis ED. Review article: current therapeutic options for radiation proctopathy. Aliment Pharmacol Ther. 2001;15(9):1253–62.

    Article  CAS  PubMed  Google Scholar 

  4. Schultheiss TE, Lee WR, Hunt MA, et al. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 1997;37:3.

    Article  CAS  PubMed  Google Scholar 

  5. Johnson MJ, Robertson GM, Frizelle FA. Management of late complications of pelvic radiation in the rectum and anus: a review. Dis Colon Rectum. 2003;46:247–259.

    Article  Google Scholar 

  6. Ajlouni M. Radiation-induced proctitis. Curr Treat Options Gastroenterol. 1999;2:20–26.

    Article  PubMed  Google Scholar 

  7. Hayne D, Vaizey CJ, Boulos PB. Anorectal injury following pelvic radiotherapy. Br J Surg. 2001;88:1037–1048.

    Article  CAS  PubMed  Google Scholar 

  8. Muthlu E, Brunig K, Morrisey M. Quality of life of patients with radiation proctitis. Gastroenterology. 2002;12:A193–194.

    Google Scholar 

  9. Eifel PJ, Levenback C, Wharton JT, Oswald MJ. Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. IntRadiat Oncol Biol Phys. 1995;32:1289–1300.

    Article  CAS  Google Scholar 

  10. Moore EM, Magrino TJ, Johnstone PA. Rectal bleeding after radiation therapy for prostate cancer: endoscopic evaluation. Radiology. 2000;217(1):215–8.

    Article  CAS  PubMed  Google Scholar 

  11. Centers for Disease Control and Prevention Inflammatory Bowel Disease (IBD). http://www.cdc.gov/ibd/ (2014).

  12. Willett CG, et al. Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasms. Int J Radiat Oncol Biol Phys. 2000;46:995–8.

    Article  CAS  PubMed  Google Scholar 

  13. Herold DM, Hanlon AL, Hanks GE. Diabetes mellitus: a predictor for late radiation morbidity. Int J Radiat Oncol Biol Phys. 1999;43:475–9.

    Article  CAS  PubMed  Google Scholar 

  14. Ross JG, Hussey DH, Mayr NA, Davis CS. Acute and late reactions to radiation therapy in patients with collagen vascular diseases. Cancer. 1993;71:3744–52.

    Article  CAS  PubMed  Google Scholar 

  15. Eifel PJ, Jhingran A, Bodurka DC, Levenback C, Thames H. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol. 2002;20(17):3651–7.

    Article  PubMed  Google Scholar 

  16. Lin A, Abu-Isa E, Griffith KA, Ben-Josef E. Toxicity of radiotherapy in patients with collagen vascular disease. Cancer 2008;113:648–53.

    Article  PubMed  Google Scholar 

  17. Hauer-jensen M, Denham JW, Andreyev HJ. Radiation enteropathy-pathogenesis, treatment and prevention. Nat Rev Gastroenterol Hepatol. 2014

    Google Scholar 

  18. Yeoh EK, Russo A, Botten R, et al. Acute effects of therapeutic irradiation for prostatic carcinoma on anorectal function. Gut. 1998;43(1):123–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Chi KD, Ehrenpreis ED, Jani AB. Accuracy and reliability of the endoscopic classification of chronic radiation-induced proctopathy using a novel grading method. J Clin Gastroenterol. 2005;39(1):42–6.

    PubMed  Google Scholar 

  20. Swaroop VS, Gostout CJ. Endoscopic treatment of chronic radiation proctopathy. J Clin Gastroenterol 1998;27:36–40.

    Article  CAS  PubMed  Google Scholar 

  21. Sharma B, Pandey D, Chiauhan V, et al. Radiation proctitis. J Indian Acad Clin Med. 2005;6:146–51.

    Google Scholar 

  22. Ehrenpreis ED, Jani A, Levitsky J, Ahn J, Hong J. A prospective, randomized, double-blind, placebo-controlled trial of retinol palmitate (vitamin A) for symptomatic chronic radiation proctopathy. Dis Colon Rectum. 2005;48(1):1–8.

    Article  PubMed  Google Scholar 

  23. Kountouras J, Zavos C. Recent advances in the management of radiation colitis. World J Gastroenterol. 2008;14(48):7289–301.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Topkan E, Karaoglu A. Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma. Oncology. 2006;71(5–6):354–60.

    Article  CAS  PubMed  Google Scholar 

  25. Grdina DJ, Kataoka Y, Murley JS. Amifostine: mechanisms of action underlying cytoprotection and chemoprevention. Drug Metabol Drug Interact. 2000;16(4):237–79.

    Article  CAS  PubMed  Google Scholar 

  26. Nicolatou-Galitis, O, et al. Systematic review of amifostine for the management of oral mucositis in cancer patients. Support Care Cancer 2013;21:357–64.

    Article  PubMed  Google Scholar 

  27. Kochhar, R, et al. Radiation-induced proctosigmoiditis. Prospective, randomized, double-blind controlled trial of oral sulfasalazine plus rectal steroids versus rectal sucralfate. Dig Dis Sci.1991;36:103–7.

    Article  CAS  PubMed  Google Scholar 

  28. Gilinsky NH, Burns DG, Barbezat GO, Levin W, Myers HS, Marks IN. The natural history of radiation-induced proctosigmoiditis: an analysis of 88 patients. Q J Med. 1983;52(205):40–53.

    CAS  PubMed  Google Scholar 

  29. Bondesen S, Rasmussen SN, Rask-madsen J, et al. 5-Aminosalicylic acid in the treatment of inflammatory bowel disease. Acta Med Scand. 1987;221(3):227–42.

    Article  CAS  PubMed  Google Scholar 

  30. Freund U, Schölmerich J, Siems H, Kluge F, Schäfer HE, Wannenmacher M. [Unwanted side-effects in using mesalazine (5-aminosalicylic acid) during radiotherapy]. Strahlenther Onkol. 1987;163(10):678–80.

    CAS  PubMed  Google Scholar 

  31. Baum CA, Biddle WL, Miner PB. Failure of 5-aminosalicylic acid enemas to improve chronic radiation proctitis. Dig Dis Sci. 1989;34(5):758–60.

    Article  CAS  PubMed  Google Scholar 

  32. Sasai T, Hiraishi H, Suzuki Y, Masuyama H, Ishida M, Terano A. Treatment of chronic post-radiation proctopathy with oral administration of sucralfate. Dis Colon Rectum 1999;42(10):1357–1357.

    Article  Google Scholar 

  33. Elson MI. The role of retinoids in wound healing. J Am Acad Dermatol. 1998;39:S79–81.

    Article  CAS  PubMed  Google Scholar 

  34. Hein R, Mensing H, Muller PK, Muller PK, Braun-Falco O, Krieg T. Effect of vitamin A and it’s derivative on collagen production and chemotactic response of fibroblasts. Br J Dermatol 1984;111:37–44.

    Article  CAS  PubMed  Google Scholar 

  35. Wilson SA, Rex DK. Endoscopic treatment of chronic radiation proctopathy. Curr Opin Gastroenterol. 2006;22(5):536–40.

    Article  PubMed  Google Scholar 

  36. Zincola R, Rutter MD, Falasco G, et al. Hemorrhagic radiation proctitis: endoscopic severity may be useful to guide therapy. Int J Colorectal Dis. 2003;18:439–44.

    Article  Google Scholar 

  37. Laughter RS, Petrilli ES, Dwyer RM, et al. Nd: YAG laser therapy of rectosigmoid bleeding due to radiation injury. Obstet Gynecol 1982;59(6 suppl):655–75

    Google Scholar 

  38. Johnson MJ, Robertson GM, Frizelle FA. Management of late complications of pelvic radiation in the rectum and anus: a review. Dis Colon Rectum. 2003;46:247–59.

    Article  Google Scholar 

  39. Fuentes D, Monserat R, Isern AM, et al. Colitis due to radiation: endoscopic management with heat probe. GEN. 1993;47:165–67.

    CAS  Google Scholar 

  40. Luna-Perez P, Rodriguez Ramirez SE. Formalin instillation for refractory radiation-induced hemorrhagic proctitis. J Surg Oncol. 2002;80(1):41–4.

    Article  CAS  PubMed  Google Scholar 

  41. Ginsberg GG, Barkun AN, Bosco JJ, et al. The argon plasma coagulator. Gastrointest Endosc 2002;55:807–810

    Article  PubMed  Google Scholar 

  42. Deepak P, Devi R, Sifuentes H, Ehrenpreis ED. Use of polyethylene glycol-based colonoscopy preparations before rectal argon plasma coagulation: lessons still to be learned by practicing gastroenterologists. J Clin Gastroenterol. 2012;46(9):803–4.

    Article  PubMed  Google Scholar 

  43. Ladas SD, Karamanolis G, Ben-Soussan E. Colonic gas explosion during therapeutic colonoscopy with electrocautery. World J Gastroenterol. 2007;13(40):5295–8.

    Article  PubMed Central  PubMed  Google Scholar 

  44. Pichon N, Maisonnette F, Cessot F, Sodji M, Sautereau D. Colonic perforations after gas explosion induced by argon plasma coagulation. Endoscopy. 2004;36(6):573.

    Article  CAS  PubMed  Google Scholar 

  45. Villavicencio RT, Rex DK, Rahmani E. Efficacy and complications of argon plasma coagulation for hematochezia related to radiation proctopathy. Gastrointest Endosc. 2002;55:70–4.

    Article  PubMed  Google Scholar 

  46. Sato Y, Takayama T, Sagawa T, et al. Argon plasma coagulation treatment of hemorrhagic radiation proctopathy: the optimal settings for application and long-term outcome. Gastrointest Endosc. 2011;73(3):543–9.

    Article  PubMed  Google Scholar 

  47. Chutkan R, Lipp A, Waye J. The argon plasma coagulator: a new and effective modality for treatment of radiation proctitis. Gastrointest Endosc 1997;45:AB27.

    Google Scholar 

  48. Zel G. Hyperbaric oxygen therapy in urology. AUA Update Ser 1990;9:114.

    Google Scholar 

  49. Dall’era MA, Hampson NB, Hsi RA, Madsen B, Corman JM. Hyperbaric oxygen therapy for radiation induced proctopathy in men treated for prostate cancer. J Urol. 2006;176(1):87–90.

    Article  PubMed  Google Scholar 

  50. Woo TC, Joseph D, Oxer H. Hyperbaric oxygen treatment for radiation proctitis. Int Radiat Oncol Biol Phys 1997;38(3):619–22.

    Article  CAS  Google Scholar 

  51. http://www.hyperbariclink.com/HealthcarePros/HealthcarePros.aspx.

  52. Mackie TR. Radiation therapy treatment optimization. Introduction. Semin Radiat Oncol. 1999;9(1):1–3.

    Article  CAS  PubMed  Google Scholar 

  53. Purdy JA. From new frontiers to new standards of practice: advances inradiotherapy planning and delivery. Front Radiat Ther Oncol. 2007;40:18–39.

    Article  PubMed  Google Scholar 

  54. Klopp AH, et al. Hematologic toxicity in RTOG 0418: a phase 2 study ofpostoperative IMRT for gynecologic cancer. Int J Radiat Oncol Biol Phys. 2013;86(1):83–90.

    Article  CAS  PubMed  Google Scholar 

  55. Samuelian JM, et al. Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2012;82(5):1981–7.

    Article  PubMed  Google Scholar 

  56. Hauer-Jensen M, Wang J, Denham JW. Bowel injury: current and evolvingmanagement strategies. Semin Radiat Oncol. 2003;13(3):357–71.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrew Mazulis .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Mazulis, A., Ehrenpreis, E. (2015). Radiation Proctopathy. In: Ehrenpreis, E., Marsh, R., Small Jr., W. (eds) Radiation Therapy for Pelvic Malignancy and its Consequences. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2217-8_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2217-8_9

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-2216-1

  • Online ISBN: 978-1-4939-2217-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics